Effects of gemfibrozil conversion to fenofibrate on lipids in patients on statin therapy.
Corbelli
John C
JC
Buffalo Cardiology and Pulmonary Associates, Williamsville, New York 14231, USA. jcorbelli@adelphia.net
Bullano
Michael F
MF
Willey
Vincent J
VJ
Cziraky
Mark J
MJ
Corbelli
Mary E
ME
Waugh
William
W
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003402:Creatine Kinase / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D011345:Fenofibrate / Q000627:therapeutic use*; D015248:Gemfibrozil / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012449:Safety; D000637:Transaminases / Q000097:blood; D016896:Treatment Outcome
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008055:Lipids; D000637:Transaminases; D003402:Creatine Kinase; D015248:Gemfibrozil; D011345:Fenofibrate